SCHEMBL777304

SCHEMBL777304

CCCCCCCOCCC

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.64
THRB P10828 2/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
MAPT P10636 1/20 0.64
USP2 O75604 1/20 0.54
CES2 O00748 2/20 0.52
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CES1 P23141 1/20 0.46
LPAR5 Q9H1C0 1/20 0.44
LPAR1 Q92633 2/20 0.42
LPAR3 Q9UBY5 2/20 0.42
LPAR2 Q9HBW0 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505160 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL87529 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL4486361 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL17713591 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL19541813 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL21044619 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL200908 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL2153214 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL1931398 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT
SCHEMBL554883 1.00 HTT (0.64) HTTTHRBMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 740 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003018-B1 ANTIMICROBIAL COMPOSITIONS GOJO IND INC (US) 2025-11-26 EP claimed
US-20250339354-A1 CONCENTRATED CONDITIONING COMPOSITIONS CONOPCO, INC., D/B/A UNILEVER (US) 2025-11-06 US claimed
EP-4532032-A1 CONCENTRATED CONDITIONING COMPOSITIONS Unilever IP Holdings B.V. (NL) 2025-04-09 EP claimed
WO-2024144565-A1 ALKALINE DEGREASING PRODUCT ECZACIBASI TUKETIM URUNLERI SANAYI VE TICARET ANONIM SIRKETI (TR) 2024-07-04 WO claimed
US-20240138407-A1 ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS ECOLAB USA INC. 2024-05-02 US claimed
WO-2023227304-A1 CONCENTRATED CONDITIONING COMPOSITIONS UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO claimed
US-11655433-B2 Method, system and product of ultrasonic cleaning of drill cuttings GREEN DRILLING TECHNOLOGIES LLC (US) 2023-05-23 US claimed
CN-115916911-A Rheology-modified tri-urethane compounds 可泰克斯公司 2023-04-04 CN claimed
US-20220264885-A1 ANTIMICROBIAL COMPOSITIONS SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2022-08-25 US claimed
US-11370985-B2 Multicomponent diesel composition NESTE OYJ (FI) 2022-06-28 US claimed
WO-2018115574-A1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2018-06-28 WO claimed
WO-2018115575-A1 A MULTICOMPONENT DIESEL COMPOSITION NESTE OYJ (FI) 2018-06-28 WO claimed
CN-103965383-A Preparation method for polyisobutylene with high reaction activity UNIV BEIJING CHEMICAL 2014-08-06 CN claimed
EP-2576736-A1 JET AVIATION FUEL COMPRISING OF ONE OR MORE ALIPHATIC ETHERS TBN Consult (DK) 2013-04-10 EP claimed
US-20130074398-A1 AVIATION FUEL BROCK-NANNESTAD THEIS (DK) 2013-03-28 US claimed
CN-101613423-B Initiation system used for synthesizing polyisobutylene with high reaction activity UNIV BEIJING CHEMICAL 2011-05-18 CN claimed
CN-102015632-A Synthesis of a PEG-6 moiety from commercial low-cost chemicals GE HEALTHCARE LTD 2011-04-13 CN claimed
CN-101613423-A A kind of initiator system that is used for synthesizing polyisobutylene with high reaction activity UNIV BEIJING CHEMICAL 2009-12-30 CN claimed
WO-2009024293-A2 STRUCTURED COSMETIC PREPARATION HAVING SKIN-MOISTURISING PROPERTIES SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) 2009-02-26 WO claimed
US-20090047313-A1 PREPARATION HAVING SKIN-MOISTURIZING PROPERTIES SCHWAN-STABILO COSMETICS GMBH & CO. KG (DE) 2009-02-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250339354-A1 CONCENTRATED CONDITIONING COMPOSITIONS CD44, CD69, PHOSPHO1 HTT 295/4885THRB 3560/4885MEN1 3152/4885
US-20240138407-A1 ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS CUTA, ARG1, LPO HTT 3200/4885THRB 4852/4885MEN1 4374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.